Thursday
SESSION XIX: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
SESSION XIX SCHEDULE
5:26 PM - 5:31 PM 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why?
  Presenters(s):Julio C. Palmaz, MD  
5:32 PM - 5:37 PM Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs?
  Presenters(s):Martin B. Leon, MD  
5:38 PM - 5:43 PM Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them?
  Presenters(s):Gregg W. Stone, MD  
5:44 PM - 5:49 PM Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease?
  Presenters(s):Michael J. Mack, MD  
5:50 PM - 5:55 PM Will Biodegradable Stents Replace Drug Eluting Stents?
  Presenters(s):Ron Waksman, MD  
5:56 PM - 6:01 PM Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When?
  Presenters(s):Xiaoyun Luo, MD / Qinghua Wu, MD  
6:02 PM - 6:07 PM Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It
  Presenters(s):Timur P. Sarac, MD  
6:08 PM - 6:13 PM Panel Discussion
END OF SESSION XIX
previous next